Middle East, North Africa, Afghanistan & Pakistan vs Saudi Arabia: Immunization, HepB3
Immunization, HepB3 over time
- Middle East, North Africa, Afghanistan & Pakistan
- Saudi Arabia
How they compare
Saudi Arabia currently reports 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 12.6%.
That makes Saudi Arabia's figure about 1.1 times Middle East, North Africa, Afghanistan & Pakistan's.
Across all 35 years both countries report, Saudi Arabia has been ahead every year.
Middle East, North Africa, Afghanistan & Pakistan ranks 24th and Saudi Arabia ranks 26th of 47 groups.
Saudi Arabia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 20.5% | 89.1% | 68.6% | Saudi Arabia |
| 2000s | 63.5% | 96.1% | 32.6% | Saudi Arabia |
| 2010s | 80.5% | 97.7% | 17.2% | Saudi Arabia |
| 2020s | 83.4% | 96.8% | 13.4% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Middle East, North Africa, Afghanistan & Pakistan or Saudi Arabia?
- Saudi Arabia, at 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan as of 2024.
- What is the difference in immunization, hepb3 between Middle East, North Africa, Afghanistan & Pakistan and Saudi Arabia?
- 12.6%, with Saudi Arabia ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan and Saudi Arabia?
- 35 years are reported by both, from 1990 to 2024.
- How do Middle East, North Africa, Afghanistan & Pakistan and Saudi Arabia rank globally for immunization, hepb3?
- Middle East, North Africa, Afghanistan & Pakistan ranks 24th and Saudi Arabia ranks 26th of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.